Structural Foundation of CTLA-4 antibodies: Emerging Platforms for Next-generation Cancer Immunotherapy.

Imjudo (tremelimumab-actl) - AstraZeneca

Yervoy (ipilimumab) - BMS

JS007 - Shanghai Junshi Bioscience

KN044 - Alphamab

http://www.ncbi.nlm.nih.gov/pubmed/42753325

Dongjin Gu; Enat Mengistu Leta; Feng Wang; Geleta Negasa Binegde; Jialong Xiong; Suaad Syed

Sep 18, 2026